Table 9.
Late adverse events recorded after concurrent high-dose intensity-modulated radiation therapy and docetaxel-based chemotherapy: gastrointestinal symptoms
| Grade | Diarrhea | Gastritis | Proctitis | Hematochezia | Highest during follow-up | Highest at last follow-up | |
|---|---|---|---|---|---|---|---|
| Cohort 1 |
1 |
1 |
1 |
1 |
1 |
3 |
1 |
| 2 |
0 |
0 |
1 |
1 |
1 |
0 |
|
| 3 |
0 |
0 |
0 |
0 |
0 |
0 |
|
| Cohort 2 |
1 |
1 |
0 |
2 |
2 |
3 |
2 |
| 2 |
1 |
0 |
1 |
0 |
2 |
0 |
|
| 3 | 0 | 0 | 0 | 0 | 0 | 0 |